Interventional management of resistant hypertension

The Lancet

Volumn 373, Issue 9671, 2009, Pages 1228-1230

  Doumas, Michael ^a   Douma, Stella ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

SPIRONOLACTONE;

ARTICLE; CAROTID SINUS PRESSORECEPTOR; DISEASE SEVERITY; HUMAN; HYPERTENSION; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; KIDNEY DENERVATION; KIDNEY FUNCTION; PATHOGENESIS; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SYMPATHECTOMY;

EID: 64049085733     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)60624-3     Document Type: Note

References (12)

1. Peet M.M. Results of subdiaphragmatic splanchnicectomy for arterial hypertension. N Eng J Med 236 (1947) 270-276
2. MacMahon S., Alderman M.H., Lindholm L.H., et al. Blood pressure related disease is a global health priority. Lancet 371 (2008) 1480-1482
3. Doumas M., Guo D., and Papademetriou V. Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions. Expert Opin Ther Targets 13 (2009) 1-13
4. Krum H., Schlaich M., Whitbourn R., et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet (2009) 10.1016/S0140-6736(09)60566-3 published online March 30.
5. Nishizaka M.K., Zaman M.A., and Calhoun D.A. Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens 16 (2003) 925-930
6. DiBona G.F. Physiology in perspective: the wisdom of the body: neural control of the kidney. Am J Physiol Regul Integr Comp Physiol 289 (2005) R633-R641
7. Burke S.L., Evans R.G., Moretti J.L., et al. Levels of renal and extrarenal sympathetic drive in angiotensin II-induced hypertension. Hypertension 51 (2008) 878-883
8. Calhoun D.A., Jones D., Textor S., et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51 (2008) 1403-1419
9. Sarafidis P.A., and Bakris G.L. Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol 52 (2008) 1749-1757
10. Wojciechowski D., Papademetriou V., Faselis C., and Fletcher R. Evaluation and treatment of resistant or difficult to control hypertension. J Clin Hypertens 10 (2008) 837-843
11. Douma S., Petidis K., Doumas M., et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 371 (2008) 1921-1926
12. Kaplan N.M. Deja vu for primary aldosteronism. Lancet 371 (2008) 1890-1891